INSTILBIO
DEAD

Serial Number

90461184

Owner

INSTIL BIO INC.

Attorney

Richard Y. Kim

Filing Date

Jan 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INSTILBIO Trademark

Serial Number: 90461184

INSTILBIO is a trademark filed by INSTIL BIO INC. on January 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage). The application is currently no longer active.

Owner Contact Info

INSTIL BIO INC. (13 trademarks)

3963 Maple Avenue, Suite 350
DALLAS, TX 75219

Entity Type: 03

Trademark Details

Filing Date

January 12, 2021

Registration Date

Not Registered

Published for Opposition

June 7, 2022

Goods & Services

Providing transportation services of patient tumor samples and biomedical services and methods, namely, the storage of the patient tumor samples for medical use of the patient tumor samples for tissue digestion and cell isolation and expansion, amplification, stimulation and cell growth, and human cells for medical use and storage, and cell population expansion and stimulation, and solid tumor tissue digestion and white blood cell and lymphocyte isolation and white blood cell and lymphocyte storage and white blood cell and lymphocyte expansion and amplification and white blood cell and lymphocyte growth and stimulation; providing medical transport services and biomedical services and methods, namely, the storage of human cells for medical use for treating patients having a tumor and solid tumor

Cells for medical and clinical use; cell growth media for growing cells for medical and clinical use and cell growth stimulatory factors being synthetic cholesterol mainly for use in growing cell cultures; white blood cell and lymphocyte growth media for growing cells for medical and clinical use and stimulatory factors in the nature of culture media for cultivating human cells; white blood cells and lymphocytes for medical and clinical use; medicaments to help assist with the regeneration of ligament and tendon fibers and cell therapies and treatments containing cells, white blood cells and lymphocytes for medical and clinical use; medical reagents for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; medical reagents for solid tumor tissue digestion, white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation

Cells for scientific and research use; cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation

Medical specimen apparatus in the nature of needles, tubing, glass slides, cups, and bags for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefrom

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 22, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 21, 2025 AITU
SOU EXTENSION 5 FILED
Jan 24, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 29, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 29, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 18, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 27, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 27, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 27, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 19, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 19, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 19, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 19, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 12, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2022 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 28, 2022 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 15, 2022 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 6, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 6, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 6, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2021 CNRT
ASSIGNED TO EXAMINER
May 6, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 13, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2021 NWOS
NEW APPLICATION ENTERED
Jan 15, 2021 NWAP